FDA approvals in 2025 introduced novel therapies and devices across ophthalmic subspecialties, emphasizing sustained efficacy ...

Combigan (brimonidine tartrate, timolol maleate; Allergan) ophthalmic solution is now available in a new 15mL bottle size for a 90-day supply. Combigan (brimonidine tartrate, timolol maleate; Allergan ...

Credit: Alcon. The active ingredient in Tryptyr is acoltremon, an agonist of transient receptor potential melastatin 8 thermoreceptors. Tryptyr significantly improved tear production compared with ...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that VEVYE® (cyclosporine ophthalmic solution) 0.1%, a patented, non‑preserved, ...

Dexamethasone sodium phosphate 0.1%; oph soln; contains benzalkonium chloride. Initial therapy: 1 or 2 drops in conjunctival sac every hour during the day and every two hours during the night. When ...

IRVINE, Calif., July 25, 2023 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize ...

Michelle Hessen, OD, discusses how cyclosporine ophthalmic solution 0.09% is safe to use in patients with dry eye, as well as where future research should turn. Michelle Hessen, OD, assistant ...

Discover comprehensive details about Diclofenac Sodium Ophthalmic Solution, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it.

An overview of the top 10 stories from Optometry Times in 2025.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Phentolamine mesylate ophthalmic solution improved ...

Discover comprehensive details about Epinastine HCl Ophthalmic Solution, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The ...

NEWARK, DE / ACCESSWIRE / June 12, 2023 / According to Future Market Insight, the global ophthalmic eye drops market is likely to reach US$ 16.21 Billion by 2033, registering a CAGR of 4.2%. This is a ...